MORSE Consulting Inc.

MORSE Consulting Inc. is delighted to welcome Zoey Li (http://ow.ly/TVmV50EVNv5) to join our team as a Reimbursement Analyst! We look forward to having Zoey make a meaningful contribution to MORSE and the market access community.

We are excited to announce that MORSE Consulting Inc. Managing Director Arvind Mani will be speaking at this year’s Canadian Association for Healthcare Reimbursement Market Access 101 program on June 8th 2021 at 12:20 EDT. He will be providing an overview on Market Access and the Canadian Landscape. Learn more and register for CAHR Market Access 101 here: http://ow.ly/kQeZ50EVb41 #healthcare #innovation #reimbursement #marketaccess

MORSE Consulting's 2021 CRaFT report offers comprehensive #data analytic insights into the metrics PMPRB proposes to utilize in their future monitoring activities published in their recent Guideline Monitoring and Evaluation Plan (GMEP) http://ow.ly/2p2b50ERivU PMPRB proposed they will be looking at whether there is any measurable change in the number or proportion of new medicines that are subject to price negotiations with the pCPA, and any changes in the average duration... of those negotiations. The PMPRB will also be evaluating any changes in the degree to which new medicines are being accepted for reimbursement by federal, provincial and territorial (FPT) public drug plans and any changes in the nature and scope of coverage To learn more about CRaFT: http://ow.ly/Jpze50ERiY9 #marketaccess #reimbursement #PMRB #pCPA

MORSE Consulting's 2021 CRaFT report offers comprehensive #data analytic insights into the metrics PMPRB proposes to utilize in their future monitoring activities published in their recent Guideline Monitoring and Evaluation Plan (GMEP) http://ow.ly/2p2b50ERivU PMPRB proposed they will be looking at whether there is any measurable change in the number or proportion of new medicines that are subject to price negotiations with the pCPA, and any changes in the average duration... of those negotiations. The PMPRB will also be evaluating any changes in the degree to which new medicines are being accepted for reimbursement by federal, provincial and territorial (FPT) public drug plans and any changes in the nature and scope of coverage To learn more about CRaFT: http://ow.ly/EQWM50ERivT #marketaccess #reimbursement #PMRB #pCPA

Quebec announced a shift towards #biosimilar drugs today, making it the fourth province in Canada to implement biosimilar #switching. Annual savings of more than $100 million for the Quebec public health plan are expected as a result of this initiative. Learn more: https://www.msss.gouv.qc.ca//salle-de-pre/communique-2864/ #marketaccess #reimbursement #publicplans

MORSE Consulting’s 2021 CRaFT report provides a breakdown of #jurisdictional #funding for #oncology and #non-oncology #drugs. To learn more about CRaFT: http://ow.ly/ac7s50EPmf4

See what MORSE Consulting Inc.'s clients are saying about the 2021 CRaFT Report. This report provides pharmaceutical companies with comprehensive data analytics insights to support their reimbursement forecasting needs. For more information on how to purchase a report, please visit: http://ow.ly/iZq850ELSEv

The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the April 2021 status of brand negotiations. Highlights: 5 products completed CADTH review... 3 products initiated pCPA negotiations 2 negotiations were completed with an LOI 3 negotiations were closed without an LOI 0 files were closed without negotiation Read More: http://ow.ly/5R2V50ELcSv #marketaccess #pharmaceutics #reimbursement #reimbursementstrategy

The new #PMPRB report (http://ow.ly/x3V150EJSwg) found that Canadian provincial #drug plans listed an average of 86% of out-patient #oncology medicines as of the end of March 2020. MORSE Consulting Inc.'s recently launched CRaFT report investigated the listing status of oncology drugs as of April 1st, 2021 and found significant differences between the listing rates of drugs that received an LOI in 2019 and those in 2020. Learn more about the CRaFT report: http://ow.ly/QBuX50EJSFk

See what MORSE Consulting Inc. 's clients are saying about the HTA Strategic Advice Service! Our HTA expert Anita Carrie has helped pharmaceutical manufacturers navigate through the pre-submission, review, as well as post-review phase of #HTA. To learn more, please visit: http://ow.ly/1x0R50EGwST

MORSE Consulting’s Arvind Mani and Lana (Chunan) Duan are excited to attend the Life Sciences Career Expo (LSCE) event as speakers. If you are interested in learning about Market Access Consulting at MORSE, be sure to join us on May 14th and May 28th! Visit the LSCE website: https://lsce.ca/attendee-registration/ #lifesciences #learning #consulting #marketaccess

MORSE Consulting Inc. is pleased to release our 2021 edition of the Canadian Reimbursement and Forecasting Timelines (CRaFT) report - A comprehensive source of reimbursement timelines and insights to inform forecasting and planning needs. Learn more: http://ow.ly/DH1150EEp8u #reimbursementstrategy #HTA #CADTH #CDR #pCODR #INESSS #pCPA #pCPAO #TTL

The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the March 2021 status of brand negotiations. Highlights: 5 products completed #CADTH review... 3 products initiated #pCPA negotiations 2 negotiations were completed with an LOI 3 negotiations were closed without an LOI 0 files were closed without negotiation Read More: https://morseconsulting.ca/covid-impact-on-the-pcpa-contin/ #marketaccess #pharmaceutics #reimbursement #reimbursementstrategy